Triple-negative breast cancer (TNBC) is a heterogeneous group of breast cancers defined by the absence of estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER2), and is minimally classified into 4 genomic subtypes (1). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.